MedPath

Bi-coastal Pharma International Limited Liability Company

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

FDA:14

Drug Approvals

Sulfacetamide Sodium and Sulfur

Approval Date
Jan 18, 2022
FDA

Sulfacetamide Sodium and Sulfur

Approval Date
Jan 18, 2022
FDA

Sodium Sulfacetamide and Sulfur Cleanser

Approval Date
Jan 18, 2022
FDA

Cephalexin

Approval Date
Jan 18, 2022
FDA

Selenium Sulfide

Approval Date
Jan 18, 2022
FDA

Sodium Sulfacetamide 9.8%, Sulfur 4.8%

Approval Date
Jan 18, 2022
FDA

Hydroquinone

Approval Date
Jan 18, 2022
FDA

Doxycycline Hyclate

Approval Date
Mar 19, 2021
FDA

Doxycycline Hyclate

Approval Date
Mar 18, 2021
FDA

Donepezil Hyrochloride

Approval Date
Jan 9, 2019
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.